Does dyslipidemia affect diabetes control in type 2 diabetic patients?

被引:0
|
作者
Kyriazis, I. A.
Zervas, E.
Mytas, D.
Stougianos, P.
Lalousis, A.
Michas, D.
Paraskevopoulos, K.
Pirgakis, V.
Partheniou, Ch.
机构
[1] Korinthos Gen Hosp, Lipid Outpatient Clin, Korinthos, Greece
[2] Korinthos Gen Hosp, Diabet Outpatient Clin, Korinthos, Greece
[3] Korinthos Gen Hosp, Dept Internal Med, Korinthos, Greece
[4] Korinthos Gen Hosp, Dept Cardiol, Korinthos, Greece
关键词
D O I
10.1016/S1567-5688(07)71359-4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:103 / 103
页数:1
相关论文
共 50 条
  • [41] The impact of religion on diabetes control in type 2 Greek diabetic patients
    Kouniakis, P
    Tsirogianni, TE
    Baltatzi, BM
    Iliadis, IF
    Hatzis, HC
    Lekkou, LA
    Kosmidou, KM
    Alevizo, AM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S613 - S613
  • [42] IMPACT OF DIABETES MANAGEMENT ON DIABETES CONTROL AND RESOURCE CONSUMPTION IN TYPE 2 DIABETIC PATIENTS
    Chan, J. C.
    Ramachandran, A.
    Mbanya, J. C.
    Shestakova, M., V
    Gagliardino, J. J.
    Ilkova, H.
    Leguet-Dinville, P.
    Chantelot, J.
    Schwarzbard, J.
    Pacou, M.
    Taieb, V
    Annemans, L.
    VALUE IN HEALTH, 2016, 19 (07) : A683 - A683
  • [43] Dyslipidemia in Type 2 Diabetic Rats
    Tan, Z. J.
    Xu, Z. R.
    Gui, Q. F.
    Wu, W. Z.
    Yang, Y. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S372 - S372
  • [44] Dyslipidemia in non-diabetic subjects from families with type 2 diabetes
    Caparevic, Z
    Simic, D
    Jelic, S
    Kostic, N
    Diligenski, V
    Bojkovic, G
    DIABETOLOGIA, 1997, 40 : 1637 - 1637
  • [45] TYPE 2 DIABETES MELLITUS. HOW SHOULD DIABETIC DYSLIPIDEMIA BE TREATED?
    Perez, A.
    Sojo, L.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2005, 17 : 40 - 51
  • [46] Gaps in dyslipidemia management among newly treated type 2 diabetes patients with dyslipidemia
    Ye, Xin
    Wygant, Gail D.
    Harley, Carolyn
    Nelson, Michael
    Grandy, Susan
    CIRCULATION, 2006, 113 (21) : E833 - E834
  • [47] Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hypertensive patients with type 2 diabetes
    Mori, Yutaka
    Itoh, Yohta
    Tajima, Naolko
    ADVANCES IN THERAPY, 2007, 24 (01) : 146 - 153
  • [48] Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hypertensive patients with type 2 diabetes
    Yutaka Mori
    Yohta Itoh
    Naoko Tajima
    Advances in Therapy, 2007, 24 : 146 - 153
  • [49] UNEXPLAINED GENDER DIFFERENCES IN DYSLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Billimek, John
    Schmalbach, Priel
    Malik, Shaista
    Sorkin, Dara H.
    Ngo-Metzger, Quyen
    Greenfield, Sheldon
    Kaplan, Sherrie H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S273 - S274
  • [50] Rosiglitazone does not adversely affect cardiac structure or function in patients with type 2 diabetes
    Sutton, MS
    Dole, JF
    Rappaport, EB
    DIABETES, 1999, 48 : A102 - A102